Literature DB >> 17116668

Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae.

Daniel E Rozen1, Lesley McGee, Bruce R Levin, Keith P Klugman.   

Abstract

The fitness cost of the genes responsible for resistance to fluoroquinolones in clinical isolates of Streptococcus pneumoniae were estimated in vitro in a common genetic background. Naturally occurring parC, parE, and gyrA loci containing mutations in the quinolone-resistance-determining regions were introduced by transformation into S. pneumoniae strain R6 individually and in combinations. The fitness of these transformants was estimated by pairwise competition experiments with a common R6 strain. On average, single par and gyr mutants responsible for low-level MIC resistance (first-step resistance) impose a fitness burden of approximately 8%. Some of these mutants engender no measurable cost, while one, a parE mutant, reduces the fitness of these bacteria by more than 40%. Most interestingly, the addition of the second par or gyr mutations required for clinically significant, high-MIC fluoroquinolone resistance does not increase the fitness burden imposed by these single genes and can even reduce it. We discuss the implications of these results for the epidemiology of fluoroquinolone resistance and the evolution of acquired resistance in treated patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17116668      PMCID: PMC1797730          DOI: 10.1128/AAC.01161-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  50 in total

Review 1.  The biological cost of antibiotic resistance.

Authors:  D I Andersson; B R Levin
Journal:  Curr Opin Microbiol       Date:  1999-10       Impact factor: 7.934

2.  Fluoroquinolone-resistant Streptococcus pneumoniae, an emerging but unrecognized public health concern: is it time to resight the goalposts?

Authors:  P G Ambrose; D Bast; G V Doern; P B Iannini; R N Jones; K P Klugman; D E Low
Journal:  Clin Infect Dis       Date:  2004-11-15       Impact factor: 9.079

3.  Fluoroquinolone-resistant pneumococci: maybe resistance isn't futile?

Authors:  Donald E Low
Journal:  Clin Infect Dis       Date:  2004-12-21       Impact factor: 9.079

4.  Interspecies recombination in type II topoisomerase genes is not a major cause of fluoroquinolone resistance in invasive Streptococcus pneumoniae isolates in the United States.

Authors:  Mathias W R Pletz; Lesley McGee; Bernard Beall; Cynthia G Whitney; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

5.  The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance.

Authors:  D J Austin; K G Kristinsson; R M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

6.  The population genetics of antibiotic resistance.

Authors:  B R Levin; M Lipsitch; V Perrot; S Schrag; R Antia; L Simonsen; N M Walker; F M Stewart
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

Review 7.  Streptococcal competence for genetic transformation: regulation by peptide pheromones.

Authors:  D A Morrison
Journal:  Microb Drug Resist       Date:  1997       Impact factor: 3.431

8.  Ciprofloxacin treatment failure in a patient with resistant Streptococcus pneumoniae infection following prior ciprofloxacin therapy.

Authors:  M W R Pletz; L McGee; O Burkhardt; H Lode; K P Klugman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-01       Impact factor: 3.267

9.  Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus.

Authors:  I Nagaev; J Björkman; D I Andersson; D Hughes
Journal:  Mol Microbiol       Date:  2001-04       Impact factor: 3.501

10.  Compensatory evolution in rifampin-resistant Escherichia coli.

Authors:  M G Reynolds
Journal:  Genetics       Date:  2000-12       Impact factor: 4.562

View more
  69 in total

1.  Genome-wide discovery of epistatic loci affecting antibiotic resistance in Neisseria gonorrhoeae using evolutionary couplings.

Authors:  Benjamin Schubert; Rohan Maddamsetti; Jackson Nyman; Maha R Farhat; Debora S Marks
Journal:  Nat Microbiol       Date:  2018-12-03       Impact factor: 17.745

Review 2.  The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts.

Authors:  R Craig MacLean; Alex R Hall; Gabriel G Perron; Angus Buckling
Journal:  Nat Rev Genet       Date:  2010-06       Impact factor: 53.242

3.  High proportion of heteroresistance in gyrA and gyrB in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.

Authors:  Brandon Eilertson; Fernanda Maruri; Amondrea Blackman; Miguel Herrera; David C Samuels; Timothy R Sterling
Journal:  Antimicrob Agents Chemother       Date:  2014-03-31       Impact factor: 5.191

4.  Compensation of fitness costs and reversibility of antibiotic resistance mutations.

Authors:  Pia Schulz zur Wiesch; Jan Engelstädter; Sebastian Bonhoeffer
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

Review 5.  Antibiotic resistance and its cost: is it possible to reverse resistance?

Authors:  Dan I Andersson; Diarmaid Hughes
Journal:  Nat Rev Microbiol       Date:  2010-03-08       Impact factor: 60.633

Review 6.  Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Authors:  Magnus Unemo; William M Shafer
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 7.  The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis.

Authors:  Borna Müller; Sonia Borrell; Graham Rose; Sebastien Gagneux
Journal:  Trends Genet       Date:  2012-12-13       Impact factor: 11.639

8.  Interplay in the selection of fluoroquinolone resistance and bacterial fitness.

Authors:  Linda L Marcusson; Niels Frimodt-Møller; Diarmaid Hughes
Journal:  PLoS Pathog       Date:  2009-08-07       Impact factor: 6.823

9.  Positive epistasis drives the acquisition of multidrug resistance.

Authors:  Sandra Trindade; Ana Sousa; Karina Bivar Xavier; Francisco Dionisio; Miguel Godinho Ferreira; Isabel Gordo
Journal:  PLoS Genet       Date:  2009-07-24       Impact factor: 5.917

10.  Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain.

Authors:  Adela G de la Campa; Carmen Ardanuy; Luz Balsalobre; Emilio Pérez-Trallero; Jose M Marimón; Asunción Fenoll; Josefina Liñares
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.